Scion Asset Management, LLC
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 97%. 4 quarters of 2024 measured against SPY adj-close benchmark.
Why follow Scion Asset Management, LLC right now?
Scion Asset Management's Q1 2026 13F (period ending 2025-09-30) reports $68M across just four positions, a concentrated structure consistent with the firm's historical approach. Molina Healthcare leads at 35.1% (125,000 shares), followed by Lululemon Athletica at 26.1% (100,000 shares — a 100% increase from the prior quarter), SLM Corp at 19.5% (480,054 shares), and Bruker Corp at 19.3% (48,334 shares).
The portfolio returned +21.3% in Q3 2025 against SPY's +17.5%, a +3.7% alpha. That follows three consecutive quarters of significant underperformance: -27.2%, -39.9%, and -56.6% alpha in Q2 2025, Q1 2025, and Q4 2024 respectively. Past performance is not indicative of future results.
Generated from public SEC filings. Not investment advice.…
Read the full 111-word brief. Pro members get the complete editorial analysis on every curated manager, plus Sunday Pulse + Stock Picks.
Unlock with Pro — $9.99/moTop holdings · current snapshot
Source: 13F-HRRecent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Scion Asset Management, LLC
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-09-30 · Last refreshed 11:08 UTC.